NCT03338621 Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients Status COMPLETED Phase PHASE2/PHASE3
NCT03315962 Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden Status COMPLETED Phase NA
NCT03305991 Tuberculosis Infection in Women of Reproductive Age and Their Infants Status COMPLETED Phase N/A
NCT03302299 Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) Status COMPLETED Phase PHASE4
NCT03266003 An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment Status COMPLETED Phase NA
NCT03255278 Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis. Status COMPLETED Phase PHASE1
NCT03230409 Impact of Nursing Interventions on Adherence to Treatment With Anti-tuberculosis Drugs in Children and Adolescents Status COMPLETED Phase NA
NCT03228095 Volatiles in Breath and Headspace Analysis - Diagnostic Markers Status ENROLLING_BY_INVITATION Phase N/A
NCT03211208 Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients Status COMPLETED Phase N/A
NCT03202693 A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects. Status COMPLETED Phase PHASE1
NCT03199690 A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers Status UNKNOWN Phase PHASE1
NCT03199339 A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371 Status COMPLETED Phase PHASE1
NCT03199313 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid Status COMPLETED Phase PHASE1
NCT03175380 Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US Status COMPLETED Phase EARLY_PHASE1
NCT03168945 Xpert Active Case-finding Trial 2: Community-based Active Case-finding for Tuberculosis in South Africa Status COMPLETED Phase NA
NCT03159364 Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections Status UNKNOWN Phase PHASE1/PHASE2
NCT03154320 A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV Status COMPLETED Phase NA
NCT03141060 Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB Status COMPLETED Phase PHASE1/PHASE2